Literature DB >> 16181323

The seven dirty little secrets of major histocompatibility complex class I antigen processing.

Jonathan W Yewdell1.   

Abstract

Every field has its dirty little secrets (DLSs): assumptions based on flimsy evidence, findings that directly contradict prevailing models or so beg comprehension that they cannot even seed reasonable alternative hypotheses. Although our natural tendency is to hug these DLSs, they should be exposed, for it is these gaps in our understanding that point to the path to enlightenment. Here, I discuss some of the DLSs of major histocompatibility complex class I antigen processing.

Mesh:

Substances:

Year:  2005        PMID: 16181323     DOI: 10.1111/j.0105-2896.2005.00309.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  32 in total

Review 1.  Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.

Authors:  Ayesha Murshid; Jianlin Gong; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Expert Rev Vaccines       Date:  2011-11       Impact factor: 5.217

Review 2.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

3.  Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.

Authors:  Yin Liu; Yuval Ramot; Antonio Torrelo; Amy S Paller; Nuo Si; Sofia Babay; Peter W Kim; Afzal Sheikh; Chyi-Chia Richard Lee; Yongqing Chen; Angel Vera; Xue Zhang; Raphaela Goldbach-Mansky; Abraham Zlotogorski
Journal:  Arthritis Rheum       Date:  2012-03

4.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

5.  Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

Authors:  Eun Ryoung Jang; Na-Ra Lee; Songhee Han; Ying Wu; Lalit Kumar Sharma; Kimberly Cornish Carmony; James Marks; Do-Min Lee; Jung-Ok Ban; Marie Wehenkel; Jin Tae Hong; Kyung Bo Kim; Wooin Lee
Journal:  Mol Biosyst       Date:  2012-06-22

6.  Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.

Authors:  Laura E Valentine; Shari M Piaskowski; Eva G Rakasz; Nathan L Henry; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis?

Authors:  Brian P Dolan; Jonathan J Knowlton; Alexandre David; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

8.  Distinct pathways generate peptides from defective ribosomal products for CD8+ T cell immunosurveillance.

Authors:  Brian P Dolan; Lily Li; Charles A Veltri; Chris M Ireland; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

Review 9.  The role of the endoplasmic reticulum in peroxisome biogenesis.

Authors:  Lazar Dimitrov; Sheung Kwan Lam; Randy Schekman
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

10.  Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses.

Authors:  Damien Zanker; Jason Waithman; Jonathan W Yewdell; Weisan Chen
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.